Keeping Track: Tumor-Agnostic Approval For Novartis; Submissions From Krystal, Menarini, And Astellas

 
• By Bridget Silverman

The latest drug development news and highlights from the Pink Sheet’s US FDA Performance Tracker

Keeping Track Feature image
Krystal Biotech's Vyjuvek is a topical, noninvasive gene therapy.

More from Cell & Gene Therapies

More from Advanced Technologies